Evercore Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Sell
10,713
-262
-2% -$36.7K 0.02% 180
2025
Q4
$1.35M Sell
10,975
-2,625
-19% -$319K 0.02% 194
2025
Q3
$1.51M Buy
13,600
+3,725
+38% +$423K 0.02% 186
2025
Q2
$1.09M Sell
9,875
-5,075
-34% -$540K 0.02% 207
2025
Q1
$1.68M Hold
14,950
0.03% 169
2024
Q4
$1.38M Buy
14,950
+2
+0% +$180 0.02% 191
2024
Q3
$1.25M Sell
14,948
-26
-0.2% -$1.98K 0.02% 202
2024
Q2
$1.03M Sell
14,974
-273
-2% -$18.2K 0.02% 214
2024
Q1
$1.12M Sell
15,247
-235
-2% -$18.1K 0.02% 213
2023
Q4
$1.25M Sell
15,482
-1,154
-7% -$89.8K 0.02% 203
2023
Q3
$1.25M Sell
16,636
-290
-2% -$22.3K 0.02% 190
2023
Q2
$1.3M Sell
16,926
-1,120
-6% -$89.3K 0.02% 189
2023
Q1
$1.5M Sell
18,046
-49
-0.3% -$4.06K 0.03% 174
2022
Q4
$1.55M Buy
18,095
+506
+3% +$40.1K 0.03% 171
2022
Q3
$1.08M Buy
17,589
+104
+0.6% +$6.56K 0.02% 195
2022
Q2
$1.08M Sell
17,485
-54
-0.3% -$3.34K 0.02% 201
2022
Q1
$1.04M Sell
17,539
-385
-2% -$24.6K 0.02% 222
2021
Q4
$1.3M Sell
17,924
-638
-3% -$43.9K 0.02% 202
2021
Q3
$1.3M Sell
18,562
-139
-0.7% -$9.77K 0.02% 197
2021
Q2
$1.29M Sell
18,701
-2,328
-11% -$155K 0.02% 200
2021
Q1
$1.36M Sell
21,029
-673
-3% -$43.4K 0.03% 198
2020
Q4
$1.26M Sell
21,702
-576
-3% -$34.8K 0.03% 189
2020
Q3
$1.41M Sell
22,278
-424
-2% -$29.4K 0.03% 172
2020
Q2
$1.75M Buy
22,702
+649
+3% +$49.7K 0.05% 153
2020
Q1
$1.65M Sell
22,053
-1,684
-7% -$116K 0.05% 146
2019
Q4
$1.54M Sell
23,737
-5,000
-17% -$326K 0.04% 176
2019
Q3
$1.82M Sell
28,737
-1,144
-4% -$74.8K 0.05% 156
2019
Q2
$2.02M Sell
29,881
-334
-1% -$22K 0.06% 151
2019
Q1
$1.97M Sell
30,215
-3,385
-10% -$225K 0.06% 149
2018
Q4
$2.1M Sell
33,600
-7,314
-18% -$511K 0.08% 128
2018
Q3
$3.16M Sell
40,914
-365
-0.9% -$27.6K 0.1% 113
2018
Q2
$2.92M Buy
41,279
+5,428
+15% +$383K 0.1% 113
2018
Q1
$2.7M Sell
35,851
-1,185
-3% -$94.2K 0.1% 113
2017
Q4
$2.65M Sell
37,036
-16,825
-31% -$1.28M 0.1% 117
2017
Q3
$4.36M Sell
53,861
-4,866
-8% -$372K 0.17% 86
2017
Q2
$4.16M Sell
58,727
-14,156
-19% -$942K 0.16% 94
2017
Q1
$4.95M Sell
72,883
-302,363
-81% -$21.3M 0.19% 87
2016
Q4
$26.9M Sell
375,246
-81,859
-18% -$6.08M 1.11% 35
2016
Q3
$36.2M Sell
457,105
-448
-0.1% -$36.4K 1.5% 24
2016
Q2
$38.2M Buy
457,553
+4,467
+1% +$396K 1.68% 17
2016
Q1
$41.6M Buy
453,086
+106,344
+31% +$9.59M 1.84% 15
2015
Q4
$35.1M Buy
346,742
+8,557
+3% +$890K 1.63% 17
2015
Q3
$33.2M Buy
338,185
+17,829
+6% +$1.98M 1.59% 15
2015
Q2
$37.5M Sell
320,356
-1,709
-0.5% -$187K 1.69% 12
2015
Q1
$31.6M Buy
322,065
+16,090
+5% +$1.63M 1.45% 19
2014
Q4
$28.8M Buy
305,975
+37,331
+14% +$3.86M 1.44% 24
2014
Q3
$28.6M Buy
268,644
+15,430
+6% +$1.51M 1.43% 20
2014
Q2
$21M Buy
253,214
+55,561
+28% +$4.32M 1.08% 34
2014
Q1
$14M Buy
197,653
+117,140
+145% +$9.19M 0.79% 47
2013
Q4
$6.05M Sell
80,513
-44,910
-36% -$3.13M 0.33% 83
2013
Q3
$7.89M Sell
125,423
-21,176
-14% -$1.27M 0.45% 71
2013
Q2
$7.52M Buy
+146,599
New +$7.64M 0.43% 72

Other funds holding GILD

Evercore Wealth Management's GILD Position: Q1 2026 in Review

Evercore Wealth Management reduced its Gilead Sciences (GILD) stake by 2.4% in Q1 2026, selling an estimated $36.7K and leaving 10,713 shares worth $1.49M. The position accounts for 0.02% of the portfolio, ranked #180.

Evercore Wealth Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $41.6M in Q1 2016. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Evercore Wealth Management held 10,713 shares of Gilead Sciences worth $1.49M as of Q1 2026.
  • Evercore Wealth Management sold 262 Gilead Sciences shares in Q1 2026, an estimated $36.7K.
  • Gilead Sciences made up 0.02% of Evercore Wealth Management's portfolio in Q1 2026, its #180 holding.
  • Evercore Wealth Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Evercore Wealth Management's Gilead Sciences position peaked at $41.6M in Q1 2016.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Evercore Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.